Donisi is the only clinically validated, contact-free device that can detect pulmonary congestion & more.
Donisi’s contact-free health measurement and decision support system enables the identification of changes nine cardiopulmonary parameters - assisting healthcare providers in (remote) data-driven decision making and timely detection of conditions such as pulmonary congestion worsening in the case of CHF patients.
Yair Brosh
Our Representatives
Company Solutions
Overview:
In early April, the US Food and Drug Administration granted Donisi De Novo clearance, making Donisi the first medical device of its kind in the world to receive FDA Clearance.
Designed to support care providers in timely identification of changes in cardiopulmonary health, Donisi’s solution is based on deep tech and backed by 26 granted patents. The system measures multiple (9) cardiopulmonary parameters with medical-grade accuracy.
Technology:
Contact-free nano-vibration motion detection via analysis of back-reflecting light patters + micromovements on an illuminated surface.
Donisi’s patented technology is agnostic to:
- Ambient lighting conditions
- Clothing layers
- Physical attributes e.g. skin color, physique, BMI
Looking For
Investors:
Next round to start H2 2021
Partners:
POCs with in-home care, senior care, remote monitoring & telehealth services